Markets

News Details

( 08/01/2018 16:10)
Aurobindo Pharma - Investor Presentation

Sub: JP Morgan Healthcare Conference

Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we hereby inform you that Company is going to participate in the 36th Annual JP Morgan Healthcare Conference in San Francisco, California to be held from 8 January 2018 to 11 January 2018 in USA.

We are enclosing the Investor Presentation which will be used in the above conference.

The presentation is being uploaded on the website of the Company -

http://www.aurobindo.com/investor-relations/investors/investor-presentation

ATTENTION INVESTORS "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case

SEBI Regn. NSE: INB231280430 I F&O: INF231280430 I BSE: INB011280436 I NSE CD: INE231280430 I MCX-SX: INE261280430

Copyright © 2017 Rikhav Securities Ltd. All rights reserved

Designed , Developed & Content Powered by DION